blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3875093

EP3875093 - HEART RATE DECREASING AGENT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.06.2024
Database last updated on 05.10.2024
FormerExamination is in progress
Status updated on  10.11.2023
FormerRequest for examination was made
Status updated on  06.08.2021
FormerThe international publication has been made
Status updated on  09.05.2020
Most recent event   Tooltip27.06.2024Application deemed to be withdrawnpublished on 31.07.2024  [2024/31]
Applicant(s)For all designated states
Furukawa Research Office Co., Ltd.
4-23-12 Seijo
Setagaya-ku
Tokyo 157-0066 / JP
[2021/36]
Inventor(s)01 / FURUKAWA, Satoru
4-23-12, Seijo, Setagaya-ku
Tokyo 157-0066 / JP
 [2021/36]
Representative(s)Brand Murray Fuller LLP
50 Eastcastle Street
London W1W 8EA / GB
[2021/36]
Application number, filing date19878056.131.10.2019
[2021/36]
WO2019JP42924
Priority number, dateJP2018020711602.11.2018         Original published format: JP 2018207116
[2021/36]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2020091014
Date:07.05.2020
Language:JA
[2020/19]
Type: A1 Application with search report 
No.:EP3875093
Date:08.09.2021
Language:EN
[2021/36]
Search report(s)International search report - published on:JP07.05.2020
(Supplementary) European search report - dispatched on:EP29.06.2022
ClassificationIPC:A61K31/513, A61P9/00, A61P9/04, A61P11/00
[2021/36]
CPC:
A61P9/04 (EP,US); A61K31/513 (EP,US); A61P11/00 (EP);
A61P9/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2021/36]
TitleGerman:HERZFREQUENZSENKENDES MITTEL[2021/36]
English:HEART RATE DECREASING AGENT[2021/36]
French:AGENT DIMINUANT LA FRÉQUENCE CARDIAQUE[2021/36]
Entry into regional phase27.04.2021Translation filed 
27.04.2021National basic fee paid 
27.04.2021Search fee paid 
27.04.2021Designation fee(s) paid 
27.04.2021Examination fee paid 
Examination procedure27.04.2021Examination requested  [2021/36]
30.01.2023Amendment by applicant (claims and/or description)
09.11.2023Despatch of a communication from the examining division (Time limit: M04)
12.03.2024Application deemed to be withdrawn, date of legal effect  [2024/31]
02.04.2024Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2024/31]
Fees paidRenewal fee
25.10.2021Renewal fee patent year 03
25.10.2022Renewal fee patent year 04
25.10.2023Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US2010190737  (BELENKY YEVSEY [US], et al) [Y] 1-3* examples 2, 4 *;
 [Y]  - MIRICA SILVIA N. ET AL, "Magnesium orotate elicits acute cardioprotection at reperfusion in isolated and in vivo rat hearts", CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, CANADA, vol. 91, no. 2, doi:10.1139/cjpp-2012-0216, ISSN 0008-4212, (20130201), pages 108 - 115, URL: http://dx.doi.org/10.1139/cjpp-2012-0216, (20220613), XP055930000 [Y] 1-3 * abstract *

DOI:   http://dx.doi.org/10.1139/cjpp-2012-0216
 [Y]  - Franklin L Rosenfeldt ET AL, "Mechanism of Cardioprotective Effect of Orotic Acid", Cardiovascular Drugs and Therapy, Boston, doi:10.1023/A:1007700716866, (19980401), pages 159 - 170, URL: https://link.springer.com/content/pdf/10.1023/A:1007700716866.pdf, (20190305), XP055564628 [Y] 1-3 * abstract *

DOI:   http://dx.doi.org/10.1023/A:1007700716866
International search[Y]JP2000516937  (WISS, Osawld) [Y] 1-5 * claims, page 11, paragraph [0002], examples 37-38 *;
 [Y]JP2012246280  (KIRIN HOLDINGS CO LTD, et al) [Y] 1-5 * claims, examples *;
 [X]  - Martynov A I, Akatova E V, "Fifteen years experience of the use of magnesium preparations in patients with mitral valve prolapse", Kardiologiia, (20191223), vol. 51, no. 6, ISSN 0022-9040, pages 60 - 65, XP009527692 [X] 1-5 * , abstract *
    [ ] - PubMed, Database accession no. 21878073
 [Y]  - SATO, NOBUHIRO et al., "Acute effect of ethanol on hemoperfusion and oxidative metabolism in the liver in vivo", Kanzo, (19810000), vol. 22, no. 4, pages 546 - 551, XP055807481 [Y] 1-5
by applicantJPS5515481
 JPH0710235
 JP2011098896
 JP2011136907
 JP2012126683
 JP2012246280
 WO2016182053
    - Keio University's Sports Medical Research Center Bulletin, (19990000), pages 33 - 39
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.